Cargando…

Effects of Metformin on COVID-19 Patients with Type 2 Diabetes: A Retrospective Study

PURPOSE: The pandemic of coronavirus disease 2019 (COVID-19) has highlighted the intricate relationship between underlying conditions and death. We designed this study to determine whether metformin therapy for type 2 diabetes mellitus (T2D) is associated with low in-hospital mortality in patients h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Ziyu, Gao, Yanxiang, Xie, Enmin, Ye, Zixiang, Li, Yike, Zhao, Xuecheng, Shen, Nan, Zheng, Jingang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461736/ https://www.ncbi.nlm.nih.gov/pubmed/37645237 http://dx.doi.org/10.2147/DMSO.S417925

Ejemplares similares

Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit
por: Ye, Zixiang, et al.
Publicado: (2023)

The prediction of in-hospital mortality in chronic kidney disease patients with coronary artery disease using machine learning models
por: Ye, Zixiang, et al.
Publicado: (2023)

Predictive value of the stress hyperglycemia ratio in dialysis patients with acute coronary syndrome: insights from a multi-center observational study
por: Xie, Enmin, et al.
Publicado: (2023)

The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease
por: Xie, Enmin, et al.
Publicado: (2023)

Association of triglyceride–glucose index with coronary severity and mortality in patients on dialysis with coronary artery disease
por: Xie, Enmin, et al.
Publicado: (2023)

Evaluating the predictive value of diabetes mellitus diagnosed according to the Chinese guidelines (2020 edition) for cardiovascular events
por: Ye, Zixiang, et al.
Publicado: (2022)

Canada acute coronary syndrome risk score predicts no-/slow-reflow in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Xie, Enmin, et al.
Publicado: (2023)

Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials
por: Li, Yike, et al.
Publicado: (2023)

The triglyceride glucose index is associated with future cardiovascular disease nonlinearly in middle-aged and elderly Chinese adults
por: Ye, Zixiang, et al.
Publicado: (2022)

Triglyceride glucose index exacerbates the risk of future cardiovascular disease due to diabetes: evidence from the China Health and Retirement Longitudinal Survey (CHARLS)
por: Ye, Zixiang, et al.
Publicado: (2022)

Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease
por: Wu, Yaxin, et al.
Publicado: (2022)

Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice
por: Tu, Yimin, et al.
Publicado: (2022)

Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease
por: Ye, Zixiang, et al.
Publicado: (2022)

Design and rationale of the ATTRACTIVE trial: a randomised trial of intrAThrombus Thrombolysis versus aspiRAtion thrombeCTomy during prImary percutaneous coronary interVEntion in ST-segment elevation myocardial infarction patients with high thrombus burden
por: Zhang, Zhen, et al.
Publicado: (2023)

Gegen Qinlian Decoction combined with Metformin for the treatment of patients with Type-2 Diabetes Mellitus: A retrospective observational study
por: Chen, Yingqi, et al.
Publicado: (2023)

Verification of the Role of ADAMTS13 in the Cardiovascular Disease Using Two-Sample Mendelian Randomization
por: Ye, Zixiang, et al.
Publicado: (2021)

Risk of Metformin in Patients With Type 2 Diabetes With COVID‐19: A Preliminary Retrospective Report
por: Gao, Yongchao, et al.
Publicado: (2020)

Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study
por: Jiang, Nan, et al.
Publicado: (2021)

Targeting Platelet Activation in Abdominal Aortic Aneurysm: Current Knowledge and Perspectives
por: Sun, Weiliang, et al.
Publicado: (2022)

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
por: Zhang, Qi, et al.
Publicado: (2020)

Metformin and Cancer in Type 2 Diabetes
por: Park, Hyeong Kyu
Publicado: (2013)

Metformin and Type 2 Diabetes Prevention
por: Aroda, Vanita R., et al.
Publicado: (2018)

Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
por: Luo, Pan, et al.
Publicado: (2020)

Pharmacodynamic Interactions between Puerarin and Metformin in Type-2 Diabetic Rats
por: Li, Zhen, et al.
Publicado: (2022)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
por: Jeon, Hyun Jeong, et al.
Publicado: (2011)

Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study
por: Cheng, Xueqi, et al.
Publicado: (2021)

Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes
por: Wang, Jingya, et al.
Publicado: (2021)

Association between metformin use and the risk of age-related macular degeneration in patients with type 2 diabetes: a retrospective study
por: Jiang, Jingjing, et al.
Publicado: (2022)

Comparison of Clinical Efficacy and Safety of Metformin Sustained-Release Tablet (II) (Dulening) and Metformin Tablet (Glucophage) in Treatment of Type 2 Diabetes Mellitus
por: Guo, Li-xin, et al.
Publicado: (2021)

The Effect of Metformin on the Clinicopathological Features of Breast Cancer With Type 2 Diabetes
por: Min, Weili, et al.
Publicado: (2020)

Metformin adherence and discontinuation among patients with type 2 diabetes: A retrospective cohort study
por: Tang, Yuexin, et al.
Publicado: (2020)

The effects of metformin in type 1 diabetes mellitus
por: Beysel, Selvihan, et al.
Publicado: (2018)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022)

Effects of Metformin on the Cerebral Metabolic Changes in Type 2 Diabetic Patients
por: Huang, Yung-Cheng, et al.
Publicado: (2014)

Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study
por: Du, Guoli, et al.
Publicado: (2020)

Effects of mulberry twig alkaloids(Sangzhi alkaloids) and metformin on blood glucose fluctuations in combination with premixed insulin-treated patients with type 2 diabetes
por: Meng, Ziyu, et al.
Publicado: (2023)

Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study
por: Mohan, Viswanathan, et al.
Publicado: (2021)

Association of serum ADAMTS-7 levels with left ventricular reverse remodeling after ST-elevation myocardial infarction
por: Wu, Wenjing, et al.
Publicado: (2018)

Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients
por: Li, Yue, et al.
Publicado: (2018)

Metformin ameliorates insulitis in STZ-induced diabetic mice
por: Han, Xue, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dek13r3i62bm712do2n9httjgp